Neuron23
A biotech company focused on developing precision medicines for neurological and immunological diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€364—545m (Dealroom.co estimates Mar 2022.)
San Francisco California (HQ)
Authorizing premium user...